Clinical trial Recruiting at 1 site Observational Ages 18 to 99

Screening and evaluation for substance use disorders at NIDA

Official title: Screening, Evaluation, and Assessment (SEA) Protocol at the NIDA IRP

Run by National Institutes of Health Clinical Center (CC) · NCT06552741 · Data updated 2026-11-12

This study is trying to see if people with and without substance use disorders can join future research at NIDA to help understand drug use and improve treatments.

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment10000 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedSeptember 4, 2024
Main results expectedJanuary 1, 2045
Study endsJanuary 1, 2047
Registry record updatedAugust 24, 2026
Trial IDNCT06552741 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 years and older, whether they currently use substances, have previously used them, or have never used them.

Probably not a fit

Patients who lack the capacity to consent to research participation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This protocol involves screening individuals with and without substance use disorders (SUD) to assess their eligibility for participation in ongoing clinical research at the National Institute on Drug Abuse (NIDA). Participants will undergo a comprehensive evaluation process that may last up to 8 hours, during which data will be collected to understand drug use behaviors and develop potential treatments for SUD. The study aims to create a registry of participants interested in future research opportunities and to enhance the understanding of the effects of SUD on various organ systems.

Why it matters

Potential benefit: If successful, this study could lead to improved treatments for individuals struggling with substance use disorders.

How similar studies have gone: Other studies have shown success in using similar screening and evaluation approaches to enhance understanding and treatment of substance use disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

This protocol is seeking individuals with current or past SUDs and/or AUD, as well as those who have never had an SUD or AUD. These individuals also may or may not be in treatment for their AUD/SUDs.

To be eligible to participate in this study, an individual must meet the following criteria:

* Age 18-99 years old.
* Proficient ability to read, write, and understand English.
* Stated willingness to comply with all screening procedures and availability for the duration of the screening period
* Ability of subject to understand and the willingness to sign a written informed consent document.

EXCLUSION CRITERIA:

Individuals who lack capacity to consent to research participation to this protocol as determined by the Evaluation to Sign Consent (ESC).

Where it's running

  • National Institute on Drug Abuse
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Lorenzo Leggio, M.D. — National Institute on Drug Abuse (NIDA)
  • Study coordinator: Shannon M Pfistner
  • Email: pfistners@nida.nih.gov
  • Phone: (800) 535-8254

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.